{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:25:06Z","timestamp":1783398306916,"version":"3.54.6"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Helsinki including Helsinki University Central Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The aim of this long-term follow-up study was to compare the disease characteristics of HLA-B27 positive and negative patients with juvenile idiopathic arthritis (JIA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study is a cohort study with consecutive cases of newly diagnosed Finnish patients with JIA according to the International League of Associations for Rheumatology (ILAR) criteria [1]. Patients were enrolled between 1997 and 2000 from a defined area of Southern Finland. Clinical data including disease activity and serology were registered during a mean period of 17.5 years.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>159 patients completed the 18-year follow-up study. HLA-B27 was available for 151 patients, of which 25% were HLA-B27 positive. Chronic uveitis was diagnosed in 30% of HLA-B27 positive and 29% of HLA-B27 negative patients. HLA-B27 positive patients had a lower prevalence of temporomandibular (TMJ) involvement than the antigen negative ones, 19% versus 28%. None of the HLA-B27 positive patients had cervical spine affected compared to 11% of antigen negative patients (p\u2009=\u20090.022). Of the HLA-B27 positive patients, 54% had had biological medication at some point during follow-up versus 25% in the negative group (p\u2009=\u20090.003). At last follow-up, 32% of antigen positive patients were not in remission compared to 18% of the antigen negative (p\u2009=\u20090.017).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The use of biological medication was more common in HLA-B27 positive patients with JIA. At the 18-year follow-up, more antigen positive patients had active disease compared HLA-B27 negative patients. This real-world follow-up study indicates that the prospects for worse outcome with HLA-B27 positivity in long-term should be taken into consideration.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12969-023-00878-9","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T19:02:19Z","timestamp":1693594939000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Disease characteristics of HLA-B27 positive and negative finnish patients with juvenile idiopathic arthritis - results of the 18-year cohort follow-up study"],"prefix":"10.1186","volume":"21","author":[{"given":"Suvi Oili Orvokki","family":"Peltoniemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Glerup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pekka","family":"Lahdenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari K","family":"Eklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristiina","family":"Aalto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,1]]},"reference":[{"key":"878_CR1","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390\u20132.","journal-title":"J Rheumatol"},{"key":"878_CR2","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1002\/art.30426","volume":"63","author":"E Nordal","year":"2011","unstructured":"Nordal E, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, et al. Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheum. 2011;63:2809\u201318.","journal-title":"Arthritis Rheum"},{"key":"878_CR3","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1093\/rheumatology\/41.12.1428","volume":"41","author":"JC Packham","year":"2002","unstructured":"Packham JC, Hall MA. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome. Rheumatology (Oxford). 2002;41:1428\u201335.","journal-title":"Rheumatology (Oxford)"},{"key":"878_CR4","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/art.10863","volume":"48","author":"HE Foster","year":"2003","unstructured":"Foster HE, Marshall N, Myers A, Dunkley P, Griffiths ID. Outcome in adults with juvenile idiopathic arthritis: a quality of life study. Arthritis Rheum. 2003;48:767\u201375.","journal-title":"Arthritis Rheum"},{"key":"878_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12969-021-00499-0","volume":"19","author":"ED Arnstad","year":"2021","unstructured":"Arnstad ED, Glerup M, Rypdal V, Peltoniemi S, Fasth A, Nielsen S, Zak M, Aalto K, Berntson L, Nordal E, Herlin T, Romundstad PR, Rygg M. Fatigue in young adults with juvenile idiopathic arthritis 18 years after disease onset: data from the prospective nordic JIA cohort. Pediatr Rheumatol Online J. 2021;19:33.","journal-title":"Pediatr Rheumatol Online J"},{"key":"878_CR6","doi-asserted-by":"crossref","unstructured":"Pruunsild C, Uibo K, Liivamagi H, Tarraste S, Talvik T, Pelkonen P. Incidence of juvenile idiopathic arthritis in children in Estonia: a prospective population-based study. Scand J Rheumatol 2007 Jan-Feb;36:7\u201313.","DOI":"10.1080\/03009740601089259"},{"key":"878_CR7","first-page":"2055","volume":"35","author":"L Berntson","year":"2008","unstructured":"Berntson L, Damgard M, Andersson-Gare B, Herlin T, Nielsen S, Nordal E, et al. HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis. J Rheumatol. 2008;35:2055\u201361.","journal-title":"J Rheumatol"},{"key":"878_CR8","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3899\/jrheum.121257","volume":"40","author":"L Berntson","year":"2013","unstructured":"Berntson L, Nordal E, Aalto K, Peltoniemi S, Herlin T, Zak M, et al. HLA-B27 predicts a more chronic disease course in an 8-year followup cohort of patients with juvenile idiopathic arthritis. J Rheumatol. 2013;40:725\u201331.","journal-title":"J Rheumatol"},{"key":"878_CR9","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/acr.23853","volume":"72","author":"M Glerup","year":"2020","unstructured":"Glerup M, Rypdal V, Arnstad ED, Ekelund M, Peltoniemi S, Aalto K, Rygg M, Toftedal P, Nielsen S, Fasth A, Berntson L, Nordal E, Herlin T, Nordic Study Group of Pediatric Rheumatology. Long-term outcomes in juvenile idiopathic arthritis: eighteen years of Follow-Up in the Population-Based nordic Juvenile Idiopathic Arthritis Cohort. Arthritis Care Res (Hoboken). 2020;72:507\u201316.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"878_CR10","first-page":"2290","volume":"31","author":"CA Wallace","year":"2004","unstructured":"Wallace CA, Ruperto N, Giannini E, Childhood Arthritis and Rheumatology Research Alliance, Pediatric Rheumatology International Trials Organization, Pediatric Rheumatology Collaborative Study Group. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol. 2004;31:2290\u20134.","journal-title":"J Rheumatol"},{"key":"878_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0049-0172(88)90019-4","volume":"17","author":"G Espada","year":"1988","unstructured":"Espada G, Babini JC, Maldonado-Cocco JA, Garc\u00eda-Morteo O. Radiologic review: the cervical spine in juvenile rheumatoid arthritis. Semin Arthritis Rheum. 1988;17:185\u201395.","journal-title":"Semin Arthritis Rheum"},{"key":"878_CR12","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s10067-008-0853-9","volume":"27","author":"S Rostom","year":"2008","unstructured":"Rostom S, Amine B, Bensabbah R, Abouqal R, Hajjaj-Hassouni N. Hip involvement in juvenile idiopathic arthritis. Clin Rheumatol. 2008;27:791\u20134.","journal-title":"Clin Rheumatol"},{"key":"878_CR13","doi-asserted-by":"publisher","first-page":"747779","DOI":"10.3389\/fped.2021.747779","volume":"9","author":"LS Sorokina","year":"2021","unstructured":"Sorokina LS, Avrusin IS, Raupov RK, Lubimova NA, Khrypov SV, Kostik MM. Hip involvement in juvenile idiopathic arthritis: a Roadmap from arthritis to total hip arthroplasty or how can we prevent hip damage? Front Pediatr. 2021;9:747779.","journal-title":"Front Pediatr"},{"key":"878_CR14","first-page":"382","volume":"72","author":"AK Libby","year":"1991","unstructured":"Libby AK, Sherry DD, Dudgeon BJ. Shoulder limitation in juvenile rheumatoid arthritis. Arch Phys Med Rehabil. 1991;72:382\u20134.","journal-title":"Arch Phys Med Rehabil"},{"key":"878_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1136\/ard.33.4.289","volume":"33","author":"J Edmonds","year":"1974","unstructured":"Edmonds J, Morris RI, Metzger AL, Bluestone R, Terasaki PI, Ansell B, Bywaters EG. Follow-up study of juvenile chronic polyarthritis with particular reference to histocompatibility antigen W. 27. Ann Rheum Dis. 1974;33:289\u201392.","journal-title":"Ann Rheum Dis"},{"key":"878_CR16","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.rdc.2013.06.002","volume":"39","author":"A Ramanathan","year":"2013","unstructured":"Ramanathan A, Srinivasalu H, Colbert R. Update on juvenile spondyloarthritis. Rheum Dis Clin North Am. 2013;39:767\u201388.","journal-title":"Rheum Dis Clin North Am"},{"key":"878_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11926-011-0198-2","volume":"13","author":"L Van Praet","year":"2011","unstructured":"Van Praet L, Van den Bosch F, Mielants H, Elewaut D. Mucosal inflammation in spondylarthritides: past, present, and future. Curr Rheumatol Rep. 2011;13:409\u201315.","journal-title":"Curr Rheumatol Rep"},{"key":"878_CR18","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/S0161-6420(01)00773-4","volume":"108","author":"K Kotaniemi","year":"2001","unstructured":"Kotaniemi K, Kautiainen H, Karma A, Aho K. Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study. Ophthalmology. 2001;108:2071\u20135.","journal-title":"Ophthalmology"},{"key":"878_CR19","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1136\/ard.2004.026955","volume":"64","author":"K Kotaniemi","year":"2005","unstructured":"Kotaniemi K, Arkela-Kautiainen M, Haapasaari J, Leirisalo-Repo M. Uveitis in young adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients. Ann Rheum Dis. 2005;64:871\u20134.","journal-title":"Ann Rheum Dis"},{"key":"878_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/BF01452257","volume":"17","author":"HA Savolainen","year":"1998","unstructured":"Savolainen HA, Lehtim\u00e4ki M, Kautiainen H, Aho K, Anttila P. HLA B27: a prognostic factor in juvenile chronic arthritis. Clin Rheumatol. 1998;17:121\u20134.","journal-title":"Clin Rheumatol"},{"key":"878_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/00002281-199507000-00001","volume":"7","author":"MA Khan","year":"1995","unstructured":"Khan MA. HLA-B27 and its subtypes in world populations. Curr Opin Rheumatol. 1995;7:263\u20139.","journal-title":"Curr Opin Rheumatol"},{"key":"878_CR22","doi-asserted-by":"crossref","unstructured":"Burgos-Vargas R. The juvenile-onset spondyloarthritides. Rheum Dis Clin North Am. 2002;28:531,60, vi.","DOI":"10.1016\/S0889-857X(02)00033-9"},{"key":"878_CR23","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1080\/03009740410005854","volume":"33","author":"CT Hsu","year":"2004","unstructured":"Hsu CT, Lin YT, Yang YH, Chiang BL. Factors affecting clinical and therapeutic outcomes of patients with juvenile rheumatoid arthritis. Scand J Rheumatol. 2004;33:312\u20137.","journal-title":"Scand J Rheumatol"},{"key":"878_CR24","doi-asserted-by":"crossref","unstructured":"Ringold S et al. 2019 American College of Rheumatology\/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis. Arthritis Care Res (Hoboken). 2019;71:717\u2013734.","DOI":"10.1002\/acr.23870"},{"key":"878_CR25","doi-asserted-by":"crossref","unstructured":"Ramiro S, et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis. 2022 Oct;21:ard\u20132022.","DOI":"10.1136\/ard-2023-223937"},{"key":"878_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.5114\/reum.2015.53133","volume":"53","author":"Z Zuber","year":"2015","unstructured":"Zuber Z, Turowska-Heydel D, Sobczyk M, Chudek J. Prevalence of HLA-B27 antigen in patients with juvenile idiopathic arthritis. Reumatologia. 2015;53:125\u201330.","journal-title":"Reumatologia"},{"key":"878_CR27","first-page":"370","volume":"29","author":"KY Fong","year":"2000","unstructured":"Fong KY. The genetics of spondyloarthropathies. Ann Acad Med Singapore. 2000;29:370\u20135.","journal-title":"Ann Acad Med Singapore"},{"key":"878_CR28","first-page":"2256","volume":"27","author":"K Minden","year":"2000","unstructured":"Minden K, Kiessling U, Listing J, Niewerth M, D\u00f6ring E, Meincke J, Sch\u00f6ntube M, Zink A. Prognosis of patients with juvenile chronic arthritis and juvenile spondyloarthropathy. J Rheumatol. 2000;27:2256\u201363.","journal-title":"J Rheumatol"},{"key":"878_CR29","first-page":"386","volume":"30","author":"B Flat\u00f8","year":"2003","unstructured":"Flat\u00f8 B, Lien G, Smerdel A, Vinje O, Dale K, Johnston V, S\u00f8rskaar D, Moum T, Ploski R, F\u00f8rre \u00d8. Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing early predictors and outcome after 14.9 years. J Rheumatol. 2003;30:386\u201393.","journal-title":"J Rheumatol"},{"key":"878_CR30","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1002\/art.21389","volume":"52","author":"CA Wallace","year":"2005","unstructured":"Wallace CA, Huang B, Bandeira M, Ravelli A, Giannini EH. Patterns of clinical remission in select categories of juvenile idiopathic arthritis. Arthritis Rheum. 2005;52:3554\u201362.","journal-title":"Arthritis Rheum"},{"key":"878_CR31","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/annrheumdis-2014-206034","volume":"75","author":"AM Selvaag","year":"2016","unstructured":"Selvaag AM, Aulie HA, Lilleby V, Flato B. Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis. Ann Rheum Dis. 2016;75:190\u20135.","journal-title":"Ann Rheum Dis"},{"key":"878_CR32","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/rheumatology\/39.2.198","volume":"39","author":"M Zak","year":"2000","unstructured":"Zak M, Pedersen FK. Juvenile chronic arthritis into adulthood: a long-term follow-up study. Rheumatology (Oxford). 2000;39:198\u2013204.","journal-title":"Rheumatology (Oxford)"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-023-00878-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-023-00878-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-023-00878-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T09:26:38Z","timestamp":1700299598000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-023-00878-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["878"],"URL":"https:\/\/doi.org\/10.1186\/s12969-023-00878-9","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]},"assertion":[{"value":"22 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval from the Medical Ethics Committee of Helsinki University Hospital was granted according to the Finnish regulations and legislation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the parents of patients younger than 15 years and from the patients who were 15 years or older.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}